
LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | Acquisition | ||
Total Funding | 000k |
Related Content
Lpath.com specializes in providing natural detox solutions and legal steroid alternatives aimed at health-conscious consumers. The company operates in the health and wellness market, catering to individuals seeking safe and effective ways to detoxify their bodies and enhance their physical performance. Lpath.com generates revenue through the direct sale of its products via its online platform, targeting a niche audience interested in natural health supplements and performance enhancers. The business model is primarily e-commerce based, leveraging digital marketing strategies to reach and engage its customer base. Key offerings include detox drinks, legal steroid alternatives, and other health supplements designed to support various wellness goals.
Keywords: natural detox, legal steroids, health supplements, e-commerce, wellness, detox drinks, performance enhancers, online sales, health-conscious, niche market.